Literature DB >> 22904583

Estimating Regression Parameters in an Extended Proportional Odds Model.

Ying Qing Chen1, Nan Hu, Su-Chun Cheng, Philippa Musoke, Lue Ping Zhao.   

Abstract

The proportional odds model may serve as a useful alternative to the Cox proportional hazards model to study association between covariates and their survival functions in medical studies. In this article, we study an extended proportional odds model that incorporates the so-called "external" time-varying covariates. In the extended model, regression parameters have a direct interpretation of comparing survival functions, without specifying the baseline survival odds function. Semiparametric and maximum likelihood estimation procedures are proposed to estimate the extended model. Our methods are demonstrated by Monte-Carlo simulations, and applied to a landmark randomized clinical trial of a short course Nevirapine (NVP) for mother-to-child transmission (MTCT) of human immunodeficiency virus type-1 (HIV-1). Additional application includes analysis of the well-known Veterans Administration (VA) Lung Cancer Trial.

Entities:  

Year:  2012        PMID: 22904583      PMCID: PMC3420072          DOI: 10.1080/01621459.2012.656021

Source DB:  PubMed          Journal:  J Am Stat Assoc        ISSN: 0162-1459            Impact factor:   5.033


  7 in total

1.  Inference for a family of survival models encompassing the proportional hazards and proportional odds models.

Authors:  David M Zucker; Song Yang
Journal:  Stat Med       Date:  2006-03-30       Impact factor: 2.373

2.  "Smooth" semiparametric regression analysis for arbitrarily censored time-to-event data.

Authors:  Min Zhang; Marie Davidian
Journal:  Biometrics       Date:  2007-10-25       Impact factor: 2.571

3.  Bayesian semiparametric proportional odds models.

Authors:  Timothy Hanson; Mingan Yang
Journal:  Biometrics       Date:  2007-03       Impact factor: 2.571

4.  Semiparametric efficient estimation in the generalized odds-rate class of regression models for right-censored time-to-event data.

Authors:  D O Scharfstein; A A Tsiatis; P B Gilbert
Journal:  Lifetime Data Anal       Date:  1998       Impact factor: 1.588

5.  Analysis of survival data by the proportional odds model.

Authors:  S Bennett
Journal:  Stat Med       Date:  1983 Apr-Jun       Impact factor: 2.373

6.  Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

Authors:  S H Eshleman; M Mracna; L A Guay; M Deseyve; S Cunningham; M Mirochnick; P Musoke; T Fleming; M Glenn Fowler; L M Mofenson; F Mmiro; J B Jackson
Journal:  AIDS       Date:  2001-10-19       Impact factor: 4.177

7.  Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.

Authors:  J Brooks Jackson; Philippa Musoke; Thomas Fleming; Laura A Guay; Danstan Bagenda; Melissa Allen; Clemensia Nakabiito; Joseph Sherman; Paul Bakaki; Maxensia Owor; Constance Ducar; Martina Deseyve; Anthony Mwatha; Lynda Emel; Corey Duefield; Mark Mirochnick; Mary Glenn Fowler; Lynne Mofenson; Paolo Miotti; Maria Gigliotti; Dorothy Bray; Francis Mmiro
Journal:  Lancet       Date:  2003-09-13       Impact factor: 79.321

  7 in total
  3 in total

1.  Predicting cumulative risk of disease onset by redistributing weights.

Authors:  Tianle Chen; Yanyuan Ma; Yuanjia Wang
Journal:  Stat Med       Date:  2015-04-06       Impact factor: 2.373

2.  Semiparametric odds rate model for modeling short-term and long-term effects with application to a breast cancer genetic study.

Authors:  Mengdie Yuan; Guoqing Diao
Journal:  Int J Biostat       Date:  2014       Impact factor: 0.968

3.  On a Shape-Invariant Hazard Regression Model with application to an HIV Prevention Study of Mother-to-Child Transmission.

Authors:  Cheng Zheng; Ying Qing Chen
Journal:  Stat Biosci       Date:  2019-10-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.